During the past decade, Los Angeles Cancer Network conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Los Angeles Cancer Network" #1 sponsor was "Bristol-Myers Squibb" with 2 trials, followed by "AVM Biotechnology Inc" with 1 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored, "Seagen Inc." with 1 trials sponsored and "Taiho Oncology, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Los Angeles Cancer Network" #1 collaborator was "Medpace, Inc." with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Los Angeles Cancer Network" are "Colorectal Neoplasms" (1 trials), "Head and Neck Cancer" (1 trials), "Lymphoid Malignancies" (1 trials), "Non-small Cell Lung Cancer" (1 trials) and "Refractory Metastatic Gastric Cancer" (1 trials). Many other conditions were trialed in "Los Angeles Cancer Network" in a lesser frequency.

Most popular intervention types in "Los Angeles Cancer Network" are "Drug" (5 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ipilimumab" (2 trials), "Nivolumab" (2 trials), "Placebo" (2 trials), "AVM0703" (1 trials) and "Atezolizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Los Angeles Cancer Network" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Los Angeles Cancer Network". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Los Angeles Cancer Network, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Los Angeles Cancer Network, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".